Navigation Links
Bayer HealthCare Pharmaceuticals Supports New Jersey Governor's School in the Sciences at Drew University
Date:7/22/2010

tyle papers and oral presentations of the work at a scientific-style conference."  

"As a company dedicated to science, we recognize the importance of unique programs like the NJGSS," said Sandra J. Oliver, vice president, public policy and government affairs at Bayer.  Located in Wayne, the company's aim is to develop and manufacture products that will improve human health by diagnosing, preventing and treating diseases.

Additionally, Making Science Make Sense® (MSMS) is Bayer's company-wide initiative that advances science literacy through hands-on, inquiry-based science education, employee volunteerism and a public education campaign. Currently, 12 Bayer sites around the country operate local MSMS programs, which together represent a national volunteer corps of more than 1,000 employees.

"Bayer HealthCare's generous support of the New Jersey Governor's School in the Sciences will continue to expose high school students throughout the state to opportunities and future careers in the sciences," said Governor Chris Christie.  "I want to thank Bayer for its contribution to this worthwhile program.  It is the support of local companies like Bayer that is invaluable in helping promote scientific learning, problem solving skills and leadership training to students throughout the Garden State."

About Drew University -- Founded in 1867, Drew is a selective, independent, coeducational university with a total enrollment of more than 2,700 students in its College of Liberal Arts, Caspersen School of Graduate Studies and Theological School.  Widely recognized for academic excellence and its tight-knit, diverse community, '/>"/>

SOURCE Bayer HealthCare Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
2. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
3. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
4. Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress
5. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
6. Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
7. FDA Approves Bayer HealthCares Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A
8. Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology
9. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
10. Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting
11. Bayer Announces New Data on Novel Anti-cancer Compound BAY 73-4506
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/14/2014)... , Sept. 14, 2014  Amgen (NASDAQ: AMGN ) ... ystolic H eart failure treatment with the ... T rial) study evaluating ivabradine in patients with chronic ... Annual Scientific Meeting of the Heart Failure Society of America ... analysis from the SHIFT study confirmed low systolic blood pressure ...
(Date:9/14/2014)... Sept. 14, 2014  Abbott announced today positive ... first prospective, randomized, controlled trial comparing the safety ... to Abbott,s market-leading metallic XIENCE family of DES.  ... , included 501 people with coronary artery ... disease. The results were featured at a late-breaking ...
(Date:9/13/2014)... , Sept. 13, 2014  Edwards Lifesciences ... leader in the science of heart valves and ... clinical outcomes for inoperable patients treated in The ... for transcatheter aortic valve replacement (TAVR) in patients ... were presented as part of the late-breaking clinical ...
Breaking Medicine Technology:Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 2Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 3Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 4Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 5Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 6Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 7Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 8Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 9ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent 2ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent 3ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent 4ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent 5Significant Patient Benefits With Edwards Sapien Valve Demonstrated In 5-Year Partner Trial Data 2
... Sanmina-SCI Corporation (Nasdaq: SANM ), a ... world,s most complex and valuable electronic and mechanical ... has been awarded ISO 13485 certification for medical ... manufacturing capabilities, and the company,s focus on meeting ...
... Sept. 8, 2011 Marshall Edwards, Inc. (Nasdaq: ... clinical development of novel therapeutics targeting cancer metabolism, announced ... of the Company,s lead drug candidate ME-143 in patients ... in collaboration with the Sarah Cannon Research Institute in ...
Cached Medicine Technology:Sanmina-SCI Kenosha, Wisconsin Facility Awarded ISO 13485 Certification for Medical Devices 2Sanmina-SCI Kenosha, Wisconsin Facility Awarded ISO 13485 Certification for Medical Devices 3Marshall Edwards Announces Initiation of Phase I Clinical Trial of Lead Oncology Drug Candidate ME-143 2Marshall Edwards Announces Initiation of Phase I Clinical Trial of Lead Oncology Drug Candidate ME-143 3
(Date:9/14/2014)... UWDress.com, is an internationally well-known designer and ... its new range of cocktail dresses under $100 ... to worldwide ladies, the company is also providing big ... blue evening gowns, black formal gowns and so on. ... , The company’s senior spokesman says, “We are ...
(Date:9/13/2014)... 13, 2014 Ticket Down is ... tickets. This beloved pop-rock group that originally formed in 1994 ... album. Fans of the group had been anticipating a new ... fans were excited yet about the release of their new ... has announced a massive worldwide tour beginning in the United ...
(Date:9/13/2014)... Termlifeinsurancequotesonline.org has released a new ... for smokers. , Smokers can now find affordable ... examination. The only application process clients have to go ... few medical questions. , Since smoking will increase ... making a decision. Comparing life insurance policies is now ...
(Date:9/13/2014)... September 13, 2014 Bedros Keuilian, founder of ... fitness marketing coach , has always been an advocate of ... most useful days are over, but the post explains that ... need to change. , “A lot of people think of ... says Keuilian. “They run a special and the only thing ...
(Date:9/13/2014)... (PRWEB) September 13, 2014 Gainesville ... the community to their official Grand Opening celebration today, ... part of the international Fit Body Boot Camp franchise, ... workouts designed to get busy people the fast results ... , “Our workouts are hard work, but we make ...
Breaking Medicine News(10 mins):Health News:UWDress.com: Elegant Cocktail Dresses Under $100 Now Offered 2Health News:Maroon 5 Tickets Now on Sale in Philadelphia, Washington DC, Nashville, San Jose, Chicago, Dallas, Los Angeles, Tacoma, Saint Paul, Vancouver, San Diego & New York 2Health News:Maroon 5 Tickets Now on Sale in Philadelphia, Washington DC, Nashville, San Jose, Chicago, Dallas, Los Angeles, Tacoma, Saint Paul, Vancouver, San Diego & New York 3Health News:Smokers Can Qualify for Life Insurance Without Taking a Medical Exam 2Health News:Renegade Fitness Marketing Expert Reveals How Personal Trainers Can Use Groupon More Effectively to Sign New Clients 2Health News:Renegade Fitness Marketing Expert Reveals How Personal Trainers Can Use Groupon More Effectively to Sign New Clients 3Health News:Gainesville Fit Body Boot Camp Announces Grand Opening of New Fitness Boot Camp 2Health News:Gainesville Fit Body Boot Camp Announces Grand Opening of New Fitness Boot Camp 3
... Reporter , THURSDAY, June 23 (HealthDay News) -- After suffering ... hopes and fears about the future are less depressed and ... In fact, 48 percent of the people who participated ... stroke were not depressed a year later, compared to 37.7 ...
... stress appears to enhance the lung-damaging effects of traffic-related ... the Keck School of Medicine of the University of ... will appear online ahead of the print edition of ... and Critical Care Medicine . "This is the ...
... team led by Johns Hopkins researchers has found that a ... with abnormally dense blood vessel growth in the skin lining ... of Familial Cancer , could lead to a quick ... DNA tests and colonoscopies, and sometimes goes unnoticed until cancer ...
... News) -- Among heart attack patients, black Americans generally ... restore blood flow to their hearts, according to a ... hospital quality, not the race of individual patients, the ... attack patients who arrive at hospitals that aren,t equipped ...
... media use, encouraging infants and young children in preschool ... active play, and requiring child care providers to promote ... to curb high rates of obesity among America,s youngest ... Medicine. The report recommends steps that ...
... the Georgia Tech Research Institute (GTRI) have developed a ... disease and certain other neurological conditions to use the ... tremors and relay the results to medical personnel. ... replace subjective tests now used to assess the severity ...
Cached Medicine News:Health News:Early Talk Therapy May Help Stroke Patients Bounce Back 2Health News:Early Talk Therapy May Help Stroke Patients Bounce Back 3Health News:Exposure to parental stress increases pollution-related lung damage in children 2Health News:Hereditary colon cancer syndrome marked by abnormally dense blood vessel growth in mouth 2Health News:Hereditary colon cancer syndrome marked by abnormally dense blood vessel growth in mouth 3Health News:Hospital Delays Tied to Racial Divide in Heart Attack Care 2Health News:Policies that promote healthy eating, activity and sleep are needed to curb obesity in infants, toddlers and preschoolers 2Health News:Policies that promote healthy eating, activity and sleep are needed to curb obesity in infants, toddlers and preschoolers 3Health News:Policies that promote healthy eating, activity and sleep are needed to curb obesity in infants, toddlers and preschoolers 4Health News:New application for iPhone may support monitoring and research on Parkinson's disease 2Health News:New application for iPhone may support monitoring and research on Parkinson's disease 3
Flattened 13 mm "Graefe type" hook, with 1.5 mm oval hole. Flat serrated handle with polished finish. Overall length: 5.6 inches....
Fine short working end. Overall length: 4.9 inches. Most popular size or model....
Designed for manipulating one piece lenses. The "Y: hook is excellent for capturing haptics and centering the lens. Straight shaft with "Y" shaped tip. Round knurled handle with dull finish. Overall ...
0.3 mm hook angled 45 degrees, 9 mm from tip to bend. Flat smooth handle with polished finish. Overall length: 4.6 inches....
Medicine Products: